Canal Insurance Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.79M | Hold |
170,000
| – | – | 2.15% | 14 |
|
|
2026
Q1 | $10.3M | Hold |
170,000
| – | – | 2.22% | 14 |
|
|
2025
Q4 | $9.17M | Hold |
170,000
| – | – | 2.22% | 15 |
|
|
2025
Q3 | $7.67M | Hold |
170,000
| – | – | 1.63% | 21 |
|
|
2025
Q2 | $7.87M | Hold |
170,000
| – | – | 1.76% | 18 |
|
|
2025
Q1 | $10.4M | Hold |
170,000
| – | – | 2.44% | 13 |
|
|
2024
Q4 | $9.62M | Hold |
170,000
| – | – | 2.49% | 14 |
|
|
2024
Q3 | $8.8M | Sell |
170,000
-30,000
| -15% | -$1.41M | 2.05% | 16 |
|
|
2024
Q2 | $8.31M | Buy |
200,000
+80,000
| +67% | +$3.58M | 2.19% | 16 |
|
|
2024
Q1 | $6.51M | Hold |
120,000
| – | – | 1.67% | 19 |
|
|
2023
Q4 | $6.16M | Hold |
120,000
| – | – | 1.7% | 19 |
|
|
2023
Q3 | $6.96M | Hold |
120,000
| – | – | 1.99% | 16 |
|
|
2023
Q2 | $7.67M | Hold |
120,000
| – | – | 2.15% | 15 |
|
|
2023
Q1 | $8.32M | Hold |
120,000
| – | – | 2.25% | 14 |
|
|
2022
Q4 | $8.63M | Hold |
120,000
| – | – | 2.36% | 14 |
|
|
2022
Q3 | $8.53M | Hold |
120,000
| – | – | 2.54% | 13 |
|
|
2022
Q2 | $9.24M | Sell |
120,000
-47,500
| -28% | -$3.62M | 2.69% | 13 |
|
|
2022
Q1 | $12.2M | Sell |
167,500
-2,500
| -1% | -$168K | 3.36% | 9 |
|
|
2021
Q4 | $10.6M | Buy |
170,000
+50,000
| +42% | +$2.93M | 3.1% | 11 |
|
|
2021
Q3 | $7.1M | Hold |
120,000
| – | – | 2.41% | 12 |
|
|
2021
Q2 | $8.02M | Hold |
120,000
| – | – | 2.82% | 11 |
|
|
2021
Q1 | $7.58M | Hold |
120,000
| – | – | 2.9% | 14 |
|
|
2020
Q4 | $7.44M | Hold |
120,000
| – | – | 3.11% | 11 |
|
|
2020
Q3 | $7.24M | Hold |
120,000
| – | – | 2.91% | 11 |
|
|
2020
Q2 | $7.06M | Hold |
120,000
| – | – | 2.78% | 11 |
|
|
2020
Q1 | $6.69M | Hold |
120,000
| – | – | 2.58% | 11 |
|
|
2019
Q4 | $7.7M | Sell |
120,000
-50,000
| -29% | -$2.86M | 2.75% | 13 |
|
|
2019
Q3 | $8.62M | Sell |
170,000
-50,000
| -23% | -$2.35M | 3.05% | 11 |
|
|
2019
Q2 | $9.98M | Hold |
220,000
| – | – | 3.28% | 10 |
|
|
2019
Q1 | $10.5M | Buy |
220,000
+35,000
| +19% | +$1.74M | 3.57% | 8 |
|
|
2018
Q4 | $9.62M | Buy |
185,000
+10,000
| +6% | +$537K | 3.56% | 9 |
|
|
2018
Q3 | $10.9M | Sell |
175,000
-55,000
| -24% | -$3.26M | 3.37% | 8 |
|
|
2018
Q2 | $12.7M | Buy |
230,000
+35,000
| +18% | +$1.89M | 4.2% | 3 |
|
|
2018
Q1 | $12.3M | Buy |
195,000
+20,000
| +11% | +$1.29M | 4.33% | 5 |
|
|
2017
Q4 | $10.7M | Sell |
175,000
-16,549
| -9% | -$1.04M | 3.82% | 7 |
|
|
2017
Q3 | $12.2M | Hold |
191,549
| – | – | 4.26% | 3 |
|
|
2017
Q2 | $10.7M | Hold |
191,549
| – | – | 3.91% | 5 |
|
|
2017
Q1 | $10.4M | Hold |
191,549
| – | – | 3.6% | 5 |
|
|
2016
Q4 | $11.2M | Hold |
191,549
| – | – | 3.97% | 5 |
|
|
2016
Q3 | $10.3M | Buy |
191,549
+60,000
| +46% | +$3.85M | 3.28% | 6 |
|
|
2016
Q2 | $9.68M | Hold |
131,549
| – | – | 3.18% | 8 |
|
|
2016
Q1 | $8.4M | Hold |
131,549
| – | – | 2.94% | 10 |
|
|
2015
Q4 | $9.05M | Hold |
131,549
| – | – | 3.33% | 6 |
|
|
2015
Q3 | $7.79M | Hold |
131,549
| – | – | 2.94% | 10 |
|
|
2015
Q2 | $8.75M | Hold |
131,549
| – | – | 2.98% | 7 |
|
|
2015
Q1 | $8.48M | Hold |
131,549
| – | – | 2.86% | 11 |
|
|
2014
Q4 | $7.76M | Hold |
131,549
| – | – | 2.61% | 13 |
|
|
2014
Q3 | $6.73M | Hold |
131,549
| – | – | 2.14% | 18 |
|
|
2014
Q2 | $6.38M | Hold |
131,549
| – | – | 1.93% | 19 |
|
|
2014
Q1 | $6.83M | Hold |
131,549
| – | – | 2.21% | 16 |
|
|
2013
Q4 | $6.99M | Hold |
131,549
| – | – | 2.33% | 17 |
|
|
2013
Q3 | $6.09M | Hold |
131,549
| – | – | 2.02% | 19 |
|
|
2013
Q2 | $5.88M | Buy |
+131,549
| New | +$5.71M | 2.09% | 17 |
|
Other funds holding BMY
AIM
FWIA
DLA
ETC
Canal Insurance Company's BMY Position: Q2 2026 in Review
Canal Insurance Company held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 170,000 shares worth $9.79M. The position accounts for 2.15% of the portfolio, ranked #14.
Canal Insurance Company first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.7M in Q2 2018. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Canal Insurance Company held 170,000 shares of Bristol-Myers Squibb worth $9.79M as of Q2 2026.
- Canal Insurance Company left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 2.15% of Canal Insurance Company's portfolio in Q2 2026, its #14 holding.
- Canal Insurance Company first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- Canal Insurance Company's Bristol-Myers Squibb position peaked at $12.7M in Q2 2018.
- 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Canal Insurance Company's 13F filing for Q2 2026, filed 21 Jul 2026.